RestorFlora is the first probiotic bacteriotherapy product that has combined three of the world’s most well studied and widely used probiotic strains – Saccharomyces Boulardii, Bacillus Subtilis HU58 and Bacillus Clausii. This combination of clinically studied, friendly probiotic yeast and probiotic bacteria offers comprehensive digestive flora support with an advanced, dual-action approach to maintain a healthy intestinal environment.
Serving Size: 1 Capsule |
Amount/Serving |
Proprietary Probiotic Blend |
360 mg |
Saccharomyces cerevisiae var boulardii (CNCM-l-1079) | 5 billion CFU |
Bacillus clausii (SC-109) | 1 billion CFU |
Bacillus subtilis, HU58™ | 1 billion CFU |
Other Ingredients: Cellulose, vegetable capsule (cellulose and water).
Ages 5+: Take 1 capsule daily with a meal or as directed by your healthcare practitioner. Children under 5 years of age, please consult with your healthcare practitioner.
Caution: If you are pregnant or nursing, taking any medication, or have a medical condition, consult your doctor before using this product. Keep out of reach of children. Do not use if safety seal is broken or missing.
No refrigeration necessary.
RestorFlora™ contains probiotics that maintain potency in the presence of gut-disrupting practices while simultaneously supporting immune function. Unlike live probiotic strains, RestorFlora™ contains strictly hardy, spore-forming bacterial species that retain their potency and effectiveness throughout the digestive process and arrive in the gut where conditions are optimal for them to revive into their living, vegetative states.
An overwhelming number of studies have been completed on the bacterial strains and yeast species within RestorFlora™. The results of these clinical trials demonstrate that a probiotic supplement containing B. subtilis HU58™, B. clausii (SC109), and S. boulardii is effective and well-tolerated support against digestive challenges, including helping overcome occasional cramping, abdominal discomfort, bloating, gas, diarrhea, and constipation. These microorganisms are stable in the presence of gut-disrupting practices, so they may provide support in preventing intestinal microbial flora alteration during gut-disrupting medication use.
Using this clinically tested biotechnology represents a novel strategy rapidly adopted by clients and practitioners worldwide!